Cyclica has announced the close of a CAD$23M Series B round of financing. The round was led by Drive Capital with participation from Chiesi Farmaceutici, GreenSky Capital, and members of Cyclica’s management team.
Funding from the round will support Cyclica’s integrated proteome-wide drug discovery platform and will expand its application within the pharma industry.